Home › Funds › WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC › MDGL
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reported holding 337,035 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$169.9M, representing 0.55% of its reported portfolio and ranking #41 among its reported holdings. WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed MDGL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's MDGL position evolved
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC first disclosed a stake in MDGL in Q4 2024 at 371,771 shares (US$114.7M). The position peaked in Q4 2025 at 354,220 shares, worth US$206.3M. Across 8 filings, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 337,035 shares valued at US$169.9M — an increase of 12,912 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 371.77K | $114.72M | New |
| Q1 2025 | 353.15K | $116.98M | Reduce |
| Q2 2025 | 350.29K | $106.01M | Reduce |
| Q3 2025 | 411.80K | $188.88M | Add |
| Q4 2025 | 354.22K | $206.28M | Reduce |
| Q1 2026 | 340.52K | $178.25M | Reduce |
| Q2 2026 | 324.12K | $174.04M | Reduce |
| Q3 2026 | 337.04K | $169.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDGL and 13F data
MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), Janus Henderson Group (US$1.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDGL
- BAKER BROS. ADVISORS LP 2.14M sh · $1.15B · Q2 2026
- RTW INVESTMENTS, LP 1.99M sh · $1.07B · Q2 2026
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Jupiter Topco LLC 1.94M sh · $1.04B · Q2 2026
- Avoro Capital Advisors LLC 1.83M sh · $984.41M · Q2 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M sh · $719.52M · Q2 2026
- ARMISTICE CAPITAL, LLC 288.00K sh · $154.64M · Q2 2026
- Rock Springs Capital Management LP 175.00K sh · $93.97M · Q2 2026
More on WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
FAQ
How long has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC held MDGL?
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed MDGL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's current position in MDGL?
As of Q3 2026, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC holds 337.04K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $169.85M, representing 0.55% of its reported portfolio and ranking #41.
Has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC been buying or selling MDGL?
In the latest 13F filing (Q3 2026), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC increased its position in MDGL. The position peaked in Q4 2025 at 354.22K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Janus Henderson Group, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.